These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 8619446)
1. Simultaneous measurement of proguanil and its metabolites in human plasma and urine by reversed-phase high-performance liquid chromatography, and its preliminary application in relation to genetically determined S-mephenytoin 4'-hydroxylation status. Kusaka M; Setiabudy R; Chiba K; Ishizaki T Am J Trop Med Hyg; 1996 Feb; 54(2):189-96. PubMed ID: 8619446 [TBL] [Abstract][Full Text] [Related]
2. Metabolic disposition of proguanil in extensive and poor metabolisers of S-mephenytoin 4'-hydroxylation recruited from an Indonesian population. Setiabudy R; Kusaka M; Chiba K; Darmansjah I; Ishizaki T Br J Clin Pharmacol; 1995 Mar; 39(3):297-303. PubMed ID: 7619672 [TBL] [Abstract][Full Text] [Related]
3. Relation between chloroguanide bioactivation to cycloguanil and the genetically determined metabolism of mephenytoin in humans. Funck-Brentano C; Bosco O; Jacqz-Aigrain E; Keundjian A; Jaillon P Clin Pharmacol Ther; 1992 May; 51(5):507-12. PubMed ID: 1587064 [TBL] [Abstract][Full Text] [Related]
4. Proguanil metabolism in relation to S-mephenytoin oxidation in a Turkish population. Basci NE; Bozkurt A; Kortunay S; Isimer A; Sayal A; Kayaalp SO Br J Clin Pharmacol; 1996 Dec; 42(6):771-3. PubMed ID: 8971434 [TBL] [Abstract][Full Text] [Related]
5. Determination of proguanil and its metabolites cycloguanil and 4-chlorophenylbiguanide in plasma, whole blood and urine by high-performance liquid chromatography. Taylor RB; Moody RR; Ochekpe NA J Chromatogr; 1987 May; 416(2):394-9. PubMed ID: 3611272 [No Abstract] [Full Text] [Related]
6. The hydroxylation of omeprazole correlates with S-mephenytoin and proguanil metabolism. Kortunay S; Basci NE; Bozkurt A; Isimer A; Sayal A; Kayaalp SO Eur J Clin Pharmacol; 1997; 53(3-4):261-4. PubMed ID: 9476042 [TBL] [Abstract][Full Text] [Related]
7. The activation of the biguanide antimalarial proguanil co-segregates with the mephenytoin oxidation polymorphism--a panel study. Ward SA; Helsby NA; Skjelbo E; Brøsen K; Gram LF; Breckenridge AM Br J Clin Pharmacol; 1991 Jun; 31(6):689-92. PubMed ID: 1867963 [TBL] [Abstract][Full Text] [Related]
8. Comparison of chloroguanide and mephenytoin for the in vivo assessment of genetically determined CYP2C19 activity in humans. Partovian C; Jacqz-Aigrain E; Keundjian A; Jaillon P; Funck-Brentano C Clin Pharmacol Ther; 1995 Sep; 58(3):257-63. PubMed ID: 7554698 [TBL] [Abstract][Full Text] [Related]
9. Proguanil metabolism is determined by the mephenytoin oxidation polymorphism in Vietnamese living in Denmark. Brøsen K; Skjelbo E; Flachs H Br J Clin Pharmacol; 1993 Aug; 36(2):105-8. PubMed ID: 8398577 [TBL] [Abstract][Full Text] [Related]
10. Analysis of proguanil and its metabolites by application of the sweeping technique in micellar electrokinetic chromatography. Taylor RB; Reid RG; Low AS J Chromatogr A; 2001 May; 916(1-2):201-6. PubMed ID: 11382292 [TBL] [Abstract][Full Text] [Related]
11. Single dose pharmacokinetics of proguanil and its metabolites in healthy subjects. Wattanagoon Y; Taylor RB; Moody RR; Ochekpe NA; Looareesuwan S; White NJ Br J Clin Pharmacol; 1987 Dec; 24(6):775-80. PubMed ID: 3440097 [TBL] [Abstract][Full Text] [Related]
12. Single dose pharmacokinetics of proguanil and its metabolites in pregnancy. Wangboonskul J; White NJ; Nosten F; ter Kuile F; Moody RR; Taylor RB Eur J Clin Pharmacol; 1993; 44(3):247-51. PubMed ID: 8491239 [TBL] [Abstract][Full Text] [Related]
13. Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms. Coller JK; Somogyi AA; Bochner F Br J Clin Pharmacol; 1999 Aug; 48(2):158-67. PubMed ID: 10417492 [TBL] [Abstract][Full Text] [Related]
14. Improved validated assay for the determination of proguanil and its metabolites in plasma, whole blood, and urine using solid-phase extraction and high-performance liquid chromatography. Bergqvist Y; Funding L; Krysèn B; Leek T; Yvell K Ther Drug Monit; 1998 Jun; 20(3):325-30. PubMed ID: 9631931 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous high-performance liquid chromatography-electrochemical detection determination of imipramine, desipramine, their 2-hydroxylated metabolites, and imipramine N-oxide in human plasma and urine: preliminary application to oxidation pharmacogenetics. Koyama E; Kikuchi Y; Echizen H; Chiba K; Ishizaki T Ther Drug Monit; 1993 Jun; 15(3):224-35. PubMed ID: 8333003 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic evaluation of proguanil: a probe phenotyping drug for the mephenytoin hydroxylase polymorphism. Somogyi AA; Reinhard HA; Bochner F Br J Clin Pharmacol; 1996 Mar; 41(3):175-9. PubMed ID: 8866915 [TBL] [Abstract][Full Text] [Related]
17. Sensitive method for the quantitative determination of proguanil and its metabolites in rat blood and plasma by liquid chromatography-mass spectrometry. Leveque NL; Charman WN; Chiu FC J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):314-21. PubMed ID: 16310420 [TBL] [Abstract][Full Text] [Related]
18. Effects of genetically determined S-mephenytoin 4-hydroxylation status and cigarette smoking on the single-dose pharmacokinetics of oral alprazolam. Otani K; Yasui N; Kaneko S; Ohkubo T; Osanai T; Sugawara K; Hayashi K; Chiba K; Ishizaki T Neuropsychopharmacology; 1997 Jan; 16(1):8-14. PubMed ID: 8981384 [TBL] [Abstract][Full Text] [Related]
19. Metabolic disposition of lansoprazole in relation to the S-mephenytoin 4'-hydroxylation phenotype status. Sohn DR; Kwon JT; Kim HK; Ishizaki T Clin Pharmacol Ther; 1997 May; 61(5):574-82. PubMed ID: 9164419 [TBL] [Abstract][Full Text] [Related]
20. [Determination of mephenytoin and 4'-hydroxymephenytoin in urine by high performance liquid chromatography]. Ruan ZR; Cheng YS; Ding DY Yao Xue Xue Bao; 1994; 29(8):624-8. PubMed ID: 7985520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]